http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100938369-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-443
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-443
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
filingDate 2002-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2010-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2010-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-100938369-B1
titleOfInvention Novel 4- (2-furoyl) aminopiperidine, synthetic intermediates thereof, preparation method thereof and use thereof as medicament
abstract Provided are novel 4- (2-furoyl) aminopiperidine represented by the following formula (I), a synthetic intermediate thereof, a preparation method thereof, and a medicament using the same as an active ingredient:n n n [Formula I]n n n n n n n n In the above formula, X is CH or N, Y is a group of the following general formula (II) or (II-a) or (III),n n n [Formula II]n n n n n n n n [Formula II-a]n n n n n n n n [Formula III]n n n n n n n n Where a, b and c are integers from 0 to 6, Z is CH 2 or NH, W is O or S, T is O or NR 15 , R 15 is H, C 1 -C 6 alkyl group, benzyl group , Phenethyl group, R 1 is H, C1-C6 alkoxycarbonyl group, benzyloxycarbonyl group and the like. The 4- (2-furoyl) aminopiperidine derivative obtained by the present invention has an opioid μ-antagonist action and has side effects of opioid μ receptor agonists selected from constipation, nausea, vomiting or pruritus, sudden constipation, and postoperative ileus. It is useful for the prevention or treatment of Usus, Paralytic Ileus, Irritable Bowel Syndrome or Chronic Pruritus.
priorityDate 2001-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421322789
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468013860
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID59714917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420394505
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468005972
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412241435
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466391698
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466582082
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466373555
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467509881
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID59714921
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467471810
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468069214
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412353365
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID59714953
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467861416
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467861369
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420419462
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23021087
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11651239
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135450129
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID59714876
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466948294
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419723222
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466752707
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID59714929
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414692126
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23021000
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411434880
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421522776
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID59714891
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466578269
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468290385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408187286
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466578268

Total number of triples: 71.